RNU6-300P

Across TCGA pan-cancer cohorts, RNU6-300P RNA is linked to patient survival in 4 of 34 cancer types, making it the most broadly survival-associated RNU6-300P data layer.

The strongest signal is observed in uterine corpus endometrial carcinoma (UCEC), where higher RNU6-300P RNA is associated with worse overall survival. In most high-consensus cancer types, elevated RNU6-300P expression acts as an unfavorable survival marker.

UCEC, THCA, and BLCA are the cancer types where RNU6-300P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
UCEC	OS	Tertile	All	0.128	0.685	<.001	90	view →
THCA	OS	Tertile	All	0.711	0.976	<.001	72	view →
BLCA	DFS	Tertile	All	0.159	0.625	.016	45	view →
GBM	OS	Tertile	All	0.086	0.415	.010	9	view →

Pink = unfavorable, green = favorable. Showing the 4 strongest of 4 lineages.

RNU6-300P–UCEC (OS)

Open the UCEC breakdown →